123 related articles for article (PubMed ID: 33110045)
1. Association of cytochrome P450 1B1 gene polymorphisms and environmental biomarkers with hypertension in Slovak midlife women.
Falbová D; Vorobeľová L; Čerňanová VC; Beňuš R; Wsólová L; Siváková D
Menopause; 2020 Nov; 27(11):1287-1294. PubMed ID: 33110045
[TBL] [Abstract][Full Text] [Related]
2. Vasomotor, urogenital, psychological, and somatic symptoms in association with CYP1B1 polymorphisms in Slovak women of different menopausal status.
Candráková Čerňanová V; Danková Z; Vorobeľová L; Cvíčelová M; Siváková D
Am J Hum Biol; 2018 May; 30(3):e23094. PubMed ID: 29285838
[TBL] [Abstract][Full Text] [Related]
3. The association of cytochrome P450 1B1 Leu432Val polymorphism with biological markers of health and menopausal symptoms in Slovak midlife women.
Luptáková L; Sivaková D; Srámeková D; Cvíčelová M
Menopause; 2012 Feb; 19(2):216-24. PubMed ID: 22011756
[TBL] [Abstract][Full Text] [Related]
4. Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.
Teng Y; He C; Zuo X; Li X
Int J Gynecol Cancer; 2013 Mar; 23(3):422-30. PubMed ID: 23370603
[TBL] [Abstract][Full Text] [Related]
5. Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis.
Cui L; Dillehay K; Chen W; Shen D; Dong Z; Li W
Mol Biol Rep; 2012 Jul; 39(7):7465-71. PubMed ID: 22327650
[TBL] [Abstract][Full Text] [Related]
6. The association of Asn453Ser polymorphism in CYP1B1 gene with selected somatic and biochemical variables in Slovak women of different menopause status.
Čerňanová V; Danková Z; Luptáková L; Cvíčelová M; Siváková D
Menopause; 2016 May; 23(5):577-83. PubMed ID: 26757271
[TBL] [Abstract][Full Text] [Related]
7. Menopausal complaints in Slovak midlife women and the impact of CYP1B1 polymorphism on their incidence.
Luptáková L; Sivtáková D; Cernanová V; Cvicelová M
Anthropol Anz; 2012; 69(4):399-415. PubMed ID: 23350153
[TBL] [Abstract][Full Text] [Related]
8. Association Between the CYP1B1 Polymorphisms and Lung Cancer Risk: A Meta-Analysis.
Chen PF; He XF; Huang GH; Wang W; Qiu ZH
Technol Cancer Res Treat; 2016 Oct; 15(5):NP73-82. PubMed ID: 26283052
[TBL] [Abstract][Full Text] [Related]
9. Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma.
Bhattacharjee A; Banerjee D; Mookherjee S; Acharya M; Banerjee A; Ray A; Sen A; ; Ray K
Mol Vis; 2008 May; 14():841-50. PubMed ID: 18483560
[TBL] [Abstract][Full Text] [Related]
10. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
11. Association of CYP1B1 Leu432Val polymorphism and lung cancer risk: an updated meta-analysis.
Lao X; Qin X; Peng Q; Chen Z; Lu Y; Liu Y; Li S
Lung; 2014 Oct; 192(5):739-48. PubMed ID: 24989113
[TBL] [Abstract][Full Text] [Related]
12. The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers.
Liu Y; Lin CS; Zhang AM; Song H; Fan CC
Tumour Biol; 2014 May; 35(5):4719-25. PubMed ID: 24453031
[TBL] [Abstract][Full Text] [Related]
13. Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis.
He XF; Wei J; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ; Liu Q; Wu LX; Wei W
PLoS One; 2014; 9(8):e100487. PubMed ID: 25115775
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of the influence of CYP1B1 polymorphisms and head and neck squamous cell carcinoma risk.
Shen M; Hu YY; Hu YK; Xie LC; Xu XM; Wu MY; Niu YM
Tumour Biol; 2014 Apr; 35(4):3891-7. PubMed ID: 24343338
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
[TBL] [Abstract][Full Text] [Related]
16. CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population.
Sillanpää P; Heikinheimo L; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Metsola K; Hirvonen A
Breast Cancer Res Treat; 2007 Sep; 104(3):287-97. PubMed ID: 17063266
[TBL] [Abstract][Full Text] [Related]
17. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
18. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
Bailey LR; Roodi N; Dupont WD; Parl FF
Cancer Res; 1998 Nov; 58(22):5038-41. PubMed ID: 9823305
[TBL] [Abstract][Full Text] [Related]
19. Interaction between genetic polymorphism of cytochrome P450-1B1 and environmental pollutants in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Eur J Cancer Prev; 2004 Feb; 13(1):83-6. PubMed ID: 15075793
[TBL] [Abstract][Full Text] [Related]
20. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]